
AI Gene Editing: Analyzing the Eli Lilly-Profluent Deal
Examine the $2.25B Eli Lilly-Profluent deal. Learn how generative AI and protein design are creating novel recombinases for kilobase-scale genome editing.

Examine the $2.25B Eli Lilly-Profluent deal. Learn how generative AI and protein design are creating novel recombinases for kilobase-scale genome editing.

Analyze the $838M Merck-Infinimmune AI antibody discovery deal. Understand how the Anthrobody screening platform and GLIMPSE language model engineer biologics.
© 2026 IntuitionLabs. All rights reserved.